Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782529 · ClinicalTrials.gov registry record · Phase 4
Knee Injections for Obese Patients With Knee Arthritis
A Phase 4 study of Osteoarthritis of Knee, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06782529: Recruiting Phase 4 study of Osteoarthritis of Knee, sponsored by Mayo Clinic.
NCT06782529 is a Phase 4 study of Osteoarthritis of Knee that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 227-participant average among 3 other Osteoarthritis of Knee trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06782529, a Phase 4 study of Osteoarthritis of Knee, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
Primary Outcome
The Numerical Pain Scale (NPS) uses a 0-10 point rating system in which the patient selects the number that describes their current pain level, where "0" represents "no pain" and "10" represents "the worst pain imaginable"
Conditions Studied
Interventions
- DRUG Triamcinolone Acetonide Low Dose
- DRUG Triamcinolone Acetonide Standard Dose
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-24 |
| Est. Completion | 2027-01-24 |
| Phase | Phase 4 |
What NCT06782529 shows while recruiting
NCT06782529 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 227-participant average among 3 other Osteoarthritis of Knee trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Osteoarthritis of Knee appearing as the primary indexed condition, and to 2 interventions - of which Triamcinolone Acetonide Low Dose is the first listed.
NCT06782529 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06782529 about?
NCT06782529 is a clinical study titled "Knee Injections for Obese Patients With Knee Arthritis". The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
What is the current status of trial NCT06782529?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2025-01-24. Estimated completion is 2027-01-24.
What conditions does trial NCT06782529 study?
This clinical trial studies the following conditions: Osteoarthritis of Knee.
What interventions are being tested in trial NCT06782529?
The interventions under investigation include: Triamcinolone Acetonide Low Dose (DRUG), Triamcinolone Acetonide Standard Dose (DRUG).
Who is sponsoring clinical trial NCT06782529?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782529 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis of Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms
RECRUITING · NA
-
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI